Quris
AI-powered platform for predicting drug efficacy and safety, reducing clinical trial failures.
About
Quris is a Bio-AI company developing a novel hybrid approach to predict drug safety in humans. Their platform uses machine-learning trained on data from "Patients-on-a-Chip" to identify drug candidates that will safely work, aiming to reduce the high failure rate in clinical trials. Quris serves the pharmaceutical industry by providing an AI safety prediction platform. Teams look it up for Healthcare, Drug Development, Life Sciences.
Frequently asked
What does Quris do?
Quris is a Healthcare company that offers Software. Teams look it up for Drug Development, Life Sciences, Biotech. It is based in Tel Aviv, Israel and was founded in 2019. Public records show about 45 people and $37M raised. Compare it on funding, headcount, reviews and nearby alternatives rather than the marketing line alone.
How much funding has Quris raised?
Quris has raised a total of $37M in funding. The most recent round on record is Seed.
Where is Quris headquartered?
Quris is headquartered in Tel Aviv, Israel.
When was Quris founded?
Quris was founded in 2019.
What industry does Quris operate in?
Quris operates in Healthcare, Drug Development, Life Sciences, Biotech, Drug Discovery.
How many employees does Quris have?
Quris has approximately 45 people on record.
Strength of the site’s backlink profile, on Ahrefs’ 0-100 Domain Rating scale. Licensed third-party data, not our opinion.
How well an AI agent can read and use this site: structured data, clean markup, and whether key facts are reachable without running JavaScript. We scan the live site.
Google PageSpeed mobile performance for the company’s own site. Measured by Google, not by us.